MCID: PDT002
MIFTS: 16

Pediatric Meningioma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Pediatric Meningioma

MalaCards integrated aliases for Pediatric Meningioma:

Name: Pediatric Meningioma 12
Childhood Meningioma 69

Classifications:



External Ids:

Disease Ontology 12 DOID:4593
NCIt 47 C8264
UMLS 69 C0280656

Summaries for Pediatric Meningioma

MalaCards based summary : Pediatric Meningioma, also known as childhood meningioma, is related to childhood brain meningioma. The drugs Cisplatin and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include brain, liver and lymph node.

Related Diseases for Pediatric Meningioma

Diseases related to Pediatric Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 childhood brain meningioma 10.9

Symptoms & Phenotypes for Pediatric Meningioma

Drugs & Therapeutics for Pediatric Meningioma

Drugs for Pediatric Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 80)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
2
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
3
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
4
Ondansetron Approved Phase 3 99614-02-5 4595
5 Antiemetics Phase 3
6 Autonomic Agents Phase 3
7 BB 1101 Phase 3
8 Dexamethasone acetate Phase 3 1177-87-3
9 Emetics Phase 3
10 Gastrointestinal Agents Phase 3,Phase 2
11 Peripheral Nervous System Agents Phase 3,Phase 1
12
Carboplatin Approved Phase 1, Phase 2 41575-94-4 10339178 498142 38904
13
Etoposide Approved Phase 1, Phase 2 33419-42-0 36462
14
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
15
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
16
Mechlorethamine Approved Phase 1, Phase 2 51-75-2 4033
17 Alkylating Agents Phase 1, Phase 2
18 Antineoplastic Agents, Phytogenic Phase 1, Phase 2
19 Etoposide phosphate Phase 1, Phase 2
20 Liver Extracts Phase 1, Phase 2
21 Protein Kinase Inhibitors Phase 1, Phase 2
22 Topoisomerase Inhibitors Phase 1, Phase 2
23 Isophosphamide mustard Phase 1, Phase 2
24
Bortezomib Approved, Investigational Phase 1 179324-69-7 387447 93860
25
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
26
Doxorubicin Approved, Investigational Phase 1 23214-92-8 31703
27
Dacarbazine Approved, Investigational Phase 1 4342-03-4 5351166
28
Lenograstim Approved Phase 1 135968-09-1
29
Temozolomide Approved, Investigational Phase 1 85622-93-1 5394
30
Lenalidomide Approved Phase 1 191732-72-6 216326
31
Romidepsin Approved, Investigational Phase 1 128517-07-7 5352062
32
Busulfan Approved, Investigational Phase 1 55-98-1 2478
33
Trioxsalen Approved Phase 1 3902-71-4 5585
34
Mebendazole Approved, Vet_approved Phase 1 31431-39-7 4030
35
Palbociclib Approved Phase 1 571190-30-2 11431660 5005498 5330286
36
Piperazine Approved, Vet_approved Phase 1 110-85-0 4837
37
Topotecan Approved, Investigational Phase 1 119413-54-6, 123948-87-8 60700
38
Doxil Approved June 1999 Phase 1 31703
39
Veliparib Investigational Phase 1 912444-00-9 11960529
40
Cediranib Investigational Phase 1 288383-20-0 9933475
41
Maleic acid Experimental Phase 1 110-16-7 444266
42 Histone Deacetylase Inhibitors Phase 1
43 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole Phase 1
44 Analgesics Phase 1
45 Analgesics, Non-Narcotic Phase 1
46 Anti-Inflammatory Agents Phase 1
47 Anti-Inflammatory Agents, Non-Steroidal Phase 1
48 Antirheumatic Agents Phase 1
49 Anti-Bacterial Agents Phase 1
50 Antibiotics, Antitubercular Phase 1

Interventional clinical trials:

(show all 33)

id Name Status NCT ID Phase Drugs
1 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
2 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
3 Dosimetry Guided PRRT With 90Y-DOTATOC Withdrawn NCT03013387 Phase 2 Amino Acids
4 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
5 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
6 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
7 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
8 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
9 SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors Completed NCT00015899 Phase 1 lonafarnib
10 Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma Completed NCT00363272 Phase 1 ispinesib
11 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Completed NCT00053963 Phase 1 romidepsin
12 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1 cilengitide
13 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
14 VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors Completed NCT00098761 Phase 1 laromustine
15 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer Completed NCT00006246 Phase 1 busulfan
16 Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer Completed NCT00053118 Phase 1 carboplatin;etoposide
17 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Completed NCT00030108 Phase 1 ixabepilone
18 ABT-751 in Treating Young Patients With Refractory Solid Tumors Completed NCT00036959 Phase 1 ABT-751
19 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors Completed NCT00303940 Phase 1 carboplatin;talabostat mesylate;temozolomide
20 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
21 Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors Recruiting NCT01682746 Phase 1 Photofrin (porfimer sodium) & photodynamic therapy.
22 Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Recruiting NCT02255461 Phase 1 palbociclib isethionate
23 SU5416 in Treating Children With Recurrent or Progressive Brain Tumors Terminated NCT00006247 Phase 1 semaxanib
24 Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors Terminated NCT00112619 Phase 1 topotecan hydrochloride
25 MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer Terminated NCT00572182 Phase 1 MK-0752
26 Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer Unknown status NCT00349024 polyvinylpyrrolidone-sodium hyaluronate gel
27 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer Completed NCT00002485
28 Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial Completed NCT00890435
29 Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain Completed NCT00452868 Early Phase 1 Donepezil
30 Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Recruiting NCT00919750
31 Collecting and Storing Tissue From Young Patients With Cancer Recruiting NCT00898755
32 Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors Withdrawn NCT00624962
33 Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors Withdrawn NCT00897858

Search NIH Clinical Center for Pediatric Meningioma

Genetic Tests for Pediatric Meningioma

Anatomical Context for Pediatric Meningioma

MalaCards organs/tissues related to Pediatric Meningioma:

39
Brain, Liver, Lymph Node

Publications for Pediatric Meningioma

Articles related to Pediatric Meningioma:

id Title Authors Year
1
Prediction of pediatric meningioma recurrence by preoperative MRI assessment. ( 27037557 )
2016
2
Pediatric meningioma: current approaches and future direction. ( 21203895 )
2011
3
Aggressive pediatric meningioma with soft tissue and lymph node metastases: a case report. ( 19086745 )
2009
4
Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization. ( 17478763 )
2007

Variations for Pediatric Meningioma

Expression for Pediatric Meningioma

Search GEO for disease gene expression data for Pediatric Meningioma.

Pathways for Pediatric Meningioma

GO Terms for Pediatric Meningioma

Sources for Pediatric Meningioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....